| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $144,498 | 3 | 100 |
Sells | $0 | 0 | 0 |
| Disbrow Joshua R. | Chief Executive Officer | 2 | $119,499 | 0 | $0 | $119,499 |
| Disbrow Jarrett | Chief Business Officer | 1 | $24,999 | 0 | $0 | $24,999 |
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.
Over the last 12 months, insiders at Aytu BioPharma, Inc. have bought $144,498 and sold $0 worth of Aytu BioPharma, Inc. stock.
On average, over the past 5 years, insiders at Aytu BioPharma, Inc. have bought $105,282 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Disbrow Joshua R. (Chief Executive Officer) — $119,499. Disbrow Jarrett (Chief Business Officer) — $24,999.
The last purchase of 66,666 shares for transaction amount of $99,999 was made by Disbrow Joshua R. (Chief Executive Officer) on 2025‑06‑09.
| 2025-06-09 | Disbrow Joshua R. | Chief Executive Officer | 66,666 0.7681% | $1.50 | $99,999 | +9.00% | ||
| 2025-06-09 | Disbrow Jarrett | Chief Business Officer | 16,666 0.192% | $1.50 | $24,999 | +9.00% | ||
| 2025-02-28 | Disbrow Joshua R. | Chief Executive Officer | 15,000 0.245% | $1.30 | $19,500 | +70.16% | ||
| 2023-06-16 | PYSZCZYMUKA GREG | Chief Commerical Officer | 12,000 0.3307% | $1.87 | $22,428 | +53.30% | ||
| 2023-06-14 | Disbrow Joshua R. | Chief Executive Officer | 14,000 0.3999% | $1.86 | $26,079 | +59.14% | ||
| 2022-12-19 | Disbrow Joshua R. | Chief Executive Officer | 112,371 0.1842% | $0.22 | $25,048 | -47.73% | ||
| 2022-12-19 | PYSZCZYMUKA GREG | Chief Commercial Officer | 100,000 0.18% | $0.24 | $24,480 | -47.73% | ||
| 2022-11-18 | Disbrow Joshua R. | Chief Executive Officer | 222,000 0.3705% | $0.24 | $52,614 | -50.00% | ||
| 2022-11-18 | Oki Mark K | Chief Financial Officer | 90,000 0.1458% | $0.23 | $20,700 | -50.00% | ||
| 2020-12-11 | ARMISTICE CAPITAL, LLC | director | 1.33M 9.5911% | $6.00 | $8M | -17.04% | ||
| 2020-04-27 | Sale | ARMISTICE CAPITAL, LLC | director | 5.11M 4.0608% | $1.82 | $9.3M | -49.75% | |
| 2020-04-15 | Sale | Cerecor Inc. | 10 percent owner | 92,777 0.082% | $1.55 | $144,092 | -33.23% | |
| 2020-03-10 | Sale | ARMISTICE CAPITAL, LLC | director | 22.03M 43.1464% | $1.42 | $31.2M | -41.46% | |
| 2019-12-20 | ARMISTICE CAPITAL, LLC | 26,000 0.1525% | $0.88 | $22,880 | +39.53% | |||
| 2019-12-19 | ARMISTICE CAPITAL, LLC | 52,788 0.3082% | $0.85 | $44,870 | +44.58% | |||
| 2019-12-19 | Disbrow Joshua R. | 55,000 0.3354% | $0.89 | $48,824 | +44.58% | |||
| 2018-12-21 | Sale | Green David A | Chief Financial Officer | 3,330 0.053% | $0.81 | $2,711 | +74.68% | |
| 2018-03-06 | Disbrow Joshua R. | Chief Executive Officer | 226,105 2.044% | $0.45 | $101,747 | -49.76% | ||
| 2018-03-06 | Disbrow Jarrett | Chief Operating Officer | 226,105 2.044% | $0.45 | $101,747 | -49.76% | ||
| 2018-03-06 | Green David A | Chief Financial Officer | 66,600 0.6021% | $0.45 | $29,970 | -49.76% |
| Disbrow Joshua R. | Chief Executive Officer | 153257 1.8922% | $332,567.69 | 10 | 0 | <0.0001% |
| Disbrow Jarrett | Chief Business Officer | 29462 0.3638% | $63,932.54 | 5 | 0 | |
| Cerecor Inc. | 10 percent owner | 9713068 119.9248% | $21.08M | 0 | 1 | |
| DOCKERY CARL | director | 5047591 62.3213% | $10.95M | 1 | 0 | |
| ARMISTICE CAPITAL, LLC | director | 1333334 16.4623% | $2.89M | 3 | 2 | <0.0001% |
| Gould Gregory A | Chief Financial Officer | 273565 3.3776% | $593,636.05 | 1 | 0 | |
| Green David A | Chief Financial Officer | 266250 3.2873% | $577,762.50 | 1 | 1 | |
| Oki Mark K | Chief Financial Officer | 190000 2.3459% | $412,300.00 | 1 | 0 | <0.0001% |
| Cantrell Gary | director | 98333 1.2141% | $213,382.61 | 1 | 0 | |
| PYSZCZYMUKA GREG | Chief Commerical Officer | 21935 0.2708% | $47,598.95 | 2 | 0 | +2.78% |
$2,058,674 | 1631 | -10.96% | $57.58M | |
$129,489,279 | 57 | 26.09% | $474.65M | |
$125,860,243 | 57 | -4.48% | $40.59M | |
$2,767,882 | 51 | 8.70% | $31.89M | |
$30,218,950 | 47 | -3.19% | $26.62M | |
$33,884,330 | 45 | 12.58% | $485.52M | |
$97,642,477 | 41 | -10.58% | $284.56M | |
$425,174,478 | 30 | -8.33% | $8.73M | |
$6,021,989 | 30 | -0.17% | $385.31M | |
$32,539,771 | 28 | 33.37% | $106.52M | |
$4,338,981 | 13 | -8.60% | $9.94M | |
$919,520 | 11 | 86.29% | $8.15M | |
$758,061 | 9 | 60.03% | $186.7M | |
$30,342 | 8 | -30.09% | $16.28M | |
Aytu BioPharma, Inc. (AYTU) | $8,171,353 | 7 | -14.29% | $17.58M |
$208,823 | 7 | -1.10% | $77.32M | |
$12,300,713 | 4 | 24.14% | $268.26M | |
$489,093 | 4 | 59.54% | $810,028.00 | |
$10,000 | 1 | -96.58% | $5.69M |
| Increased Positions | 14 | +38.89% | 513,920 | +13.73% |
| Decreased Positions | 10 | -27.78% | 674,805 | -18.03% |
| New Positions | 7 | New | 439,308 | New |
| Sold Out Positions | 5 | Sold Out | 590,856 | Sold Out |
| Total Postitions | 40 | +11.11% | 4M | -4.3% |
| Nantahala Capital Management, Llc | $3,010.00 | 10.87% | 1.09M | 0 | 0% | 2025-09-30 |
| Stonepine Capital Management, Llc | $2,470.00 | 8.92% | 891,855 | +79,179 | +9.74% | 2025-09-30 |
| Awm Investment Company, Inc. | $1,716.00 | 6.2% | 619,574 | -300 | -0.05% | 2025-09-30 |
| Vanguard Group Inc | $772.00 | 2.79% | 278,583 | +250,695 | +898.93% | 2025-09-30 |
| Diadema Partners Lp | $755.00 | 2.73% | 272,670 | +272,670 | New | 2025-09-30 |
| Renaissance Technologies Llc | $263.00 | 0.95% | 95,123 | +5,210 | +5.79% | 2025-09-30 |
| Geode Capital Management, Llc | $197.00 | 0.71% | 71,006 | +17,137 | +31.81% | 2025-09-30 |
| Two Sigma Investments, Lp | $190.00 | 0.69% | 68,736 | +33,701 | +96.19% | 2025-09-30 |
| Persistent Asset Partners Ltd | $173.00 | 0.63% | 62,452 | +62,452 | New | 2025-09-30 |
| Two Sigma Advisers, Lp | $110.00 | 0.4% | 39,800 | +39,800 | New | 2025-09-30 |